Ignite Creation Date:
2024-05-05 @ 11:45 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00129038
Status:
COMPLETED
Last Update Posted:
2013-10-29
First Post:
2005-08-10
Brief Title:
Modified-release DipyridamoleAspirin 200mg25mg bd Versus Aspirin 75mg in Aspirin-resistant Patients
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Organization Data
Organization:
Boehringer Ingelheim
Class:
INDUSTRY
Study ID:
9169
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Boehringer Ingelheim
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Boehringer Ingelheim Study Chair
Old Organization:
Boehringer Ingelheim